| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 06/29/1999 | US5916773 Recombinant production of fusion proteins comprising erythropoietin and GM-CSF components |
| 06/29/1999 | US5916772 The dna encoding saporin and dna encoding the n-terminal extension are selected such that saporin-containing protein is cytotoxic upon internalization by selected cells. |
| 06/29/1999 | US5916771 One advantage of the method of the invention is that cells expressing a single component of the final multi-component protein can be individually selected for one or more desired characteristics, such as a high rate of production. |
| 06/29/1999 | US5916558 Recombinant polypeptides and peptides, nucleic acids coding for the same and use of these polypeptides and peptides in the diagnostic of tuberculosis |
| 06/29/1999 | CA1340612C Cell specific cytotoxic agents derived from diphtheria toxin |
| 06/29/1999 | CA1340610C Monoclonal antibody to polymorphic hla determinant-b27 |
| 06/24/1999 | WO1999031508A1 C-terminal region of agouti-related transcript (art) protein |
| 06/24/1999 | WO1999031246A1 Compounds and methods for the detection and prevention of t. cruzi infection |
| 06/24/1999 | CA2314971A1 C-terminal region of agouti-related transcript (art) protein |
| 06/23/1999 | EP0923606A1 ANTIGENIC FUSIONPROTEIN CARRYING GAL$g(a)1,3GAL EPITOPES |
| 06/23/1999 | EP0628639B1 Reconstituted human antibody against human interleukin 6 receptor |
| 06/23/1999 | EP0605522B1 Methods for the production of humanized antibodies |
| 06/23/1999 | EP0598816B1 Osp a proteins of borrelia burgdorferi subgroups, encoding genes and vaccines |
| 06/22/1999 | US5914260 Fish pancreatic disease virus |
| 06/22/1999 | US5914111 Inhibiting t-cell activation by administering polypeptide having amino acids 1-92 of lymphocyte functioning associated antigen-3 joined to different protein or polypeptide comprising portion of immunoglobulin |
| 06/22/1999 | CA1340600C Bacillus thuringiensis p-2 toxin gene |
| 06/22/1999 | CA1340597C Expression vectors containing pl promoter, and engineered restriction site for convenient replacement of ribosomal binding site, plasmids containing the vectors, hosts containing the plasmids and related methods |
| 06/17/1999 | WO1999029878A2 Methods of producing anti-angiogenic proteins: endostatin, angiostatin or restin, using a pichia yeast expression system |
| 06/17/1999 | WO1999029863A1 Human interferon-epsilon: a type i interferon |
| 06/17/1999 | WO1999029860A1 Cadherin-like polypeptides, methods and compositions related thereto |
| 06/17/1999 | WO1999029856A1 Restin and methods of use thereof |
| 06/17/1999 | WO1999029855A1 Mutants of endostatin, 'em 1' having anti-angiogenic activity and methods of use thereof |
| 06/17/1999 | WO1999029853A1 Cadherin-like polypeptides, methods and compositions related thereto |
| 06/17/1999 | WO1999029838A1 Fibrinogen-converting enzyme hybrids |
| 06/17/1999 | WO1999029732A2 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation |
| 06/17/1999 | WO1999029721A1 Anti-pathogen system and methods of use thereof |
| 06/17/1999 | CA2693296A1 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation |
| 06/17/1999 | CA2314267A1 Anti-pathogen system and methods of use thereof |
| 06/17/1999 | CA2313705A1 Restin and methods of use thereof |
| 06/17/1999 | CA2313251A1 Mutants of endostatin, "em 1" having anti-angiogenic activity and methods of use thereof |
| 06/17/1999 | CA2312697A1 Cadherin-like polypeptides, methods and compositions related thereto |
| 06/17/1999 | CA2312476A1 Fibrinogen-converting enzyme hybrids |
| 06/17/1999 | CA2312287A1 Methods of producing anti-angiogenic proteins: endostatin, angiostatin or restin, using a pichia yeast expression system |
| 06/17/1999 | CA2311681A1 Human interferon-epsilon: a type i interferon |
| 06/16/1999 | EP0797582A4 Phosphotyrosine assay and peptides for use therein |
| 06/15/1999 | US5912411 Mice transgenic for a tetracycline-inducible transcriptional activator |
| 06/15/1999 | US5912170 Redirection of cellular immunity by protein-tyrosine kinase chimeras |
| 06/15/1999 | US5912123 Detection of the leptin receptor in reproductive organs and methods for regulating reproductive biology |
| 06/15/1999 | US5911989 Antibodies |
| 06/10/1999 | WO1999028484A1 Proteinase inhibitor fusion proteins |
| 06/10/1999 | WO1999028478A1 Preparation and use of recombinant influenza a virus m2 constructs and vaccines |
| 06/10/1999 | WO1999028475A2 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
| 06/10/1999 | WO1999028469A1 Compositions and methods for inducing gene expression |
| 06/10/1999 | WO1999028467A1 Human thyroid protein zsig45 and dna encoding same |
| 06/10/1999 | WO1999028462A2 Polypeptides and nucleic acids encoding the same |
| 06/10/1999 | WO1999013095A3 Use of multivalent chimeric peptide-loaded, mhc/ig molecules to detect, activate or suppress antigen-specific t cell-dependent immune responses |
| 06/10/1999 | WO1999010375A3 Vaccine against hpv |
| 06/10/1999 | CA2312050A1 Proteinase inhibitor fusion proteins |
| 06/10/1999 | CA2312048A1 Human thyroid protein zsig45 and dna encoding same |
| 06/10/1999 | CA2311640A1 Polypeptides and nucleic acids encoding the same |
| 06/10/1999 | CA2309228A1 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
| 06/09/1999 | EP0920630A2 Prion protein binding proteins and uses thereof |
| 06/09/1999 | EP0920510A1 GnRH-LEUKOTOXIN CHIMERAS |
| 06/08/1999 | US5910574 Human trk receptors and neurotrophic factor inhibitors |
| 06/08/1999 | US5910573 Monomeric and dimeric antibody-fragment fusion proteins |
| 06/08/1999 | US5910481 Hybrid proteins with modified activity |
| 06/08/1999 | US5910416 Adrenomedullin |
| 06/03/1999 | WO1999027121A1 Development of viruses resistant to inactivation by the human complement system |
| 06/03/1999 | WO1999027110A1 Hormone-dependent forms of the adeno-associated virus, rep proteins, dna sequences coding for them, vectors containing them, and regulatory methods of their intracellular activity |
| 06/03/1999 | WO1999027105A2 Chlamydia pneumoniae genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
| 06/03/1999 | WO1999009166A3 Prostate tumor polynucleotide and antigen compositions |
| 06/03/1999 | WO1999006551B1 5' ESTs FOR SECRETED PROTEINS IDENTIFIED FROM BRAIN TISSUES |
| 06/03/1999 | CA2307846A1 Chlamydia pneumoniae genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
| 06/02/1999 | EP0919566A2 Antimicrobial peptides and their use against plant pathogens |
| 06/02/1999 | EP0680513B1 Lysosomal targeting of immunogens |
| 06/01/1999 | US5908845 Polyether nucleic acids |
| 06/01/1999 | US5908756 Protein inhibitor of neuronal nitric oxide synthase |
| 06/01/1999 | US5908626 Genetic engineering |
| 06/01/1999 | CA1340577C Recombinant systems for expressions of cholera b-subunit with the aid of foreign promoters and/or leader peptides |
| 05/27/1999 | WO1999025849A1 Single-chain bifunctional glycoprotein hormones |
| 05/27/1999 | WO1999025835A1 Improvements relating to protein accumulation |
| 05/27/1999 | WO1999025834A1 Dna19355 polypeptide, a tumor necrosis factor homolog |
| 05/27/1999 | WO1999025829A2 Cdk2 protein and cdk2 protein complexes |
| 05/27/1999 | WO1999025828A1 A human 2-19 protein homologue, z219c |
| 05/27/1999 | WO1999025739A1 Variable region fusion peptides that form effector complexes in the presence of antigen |
| 05/27/1999 | WO1999025735A1 Chimeric pre-activated transcription factors |
| 05/27/1999 | WO1999014330A8 DcR3 POLYPEPTIDE, A TNFR HOMOLOG |
| 05/27/1999 | CA2320399A1 A human 2-19 protein homologue, z219c |
| 05/27/1999 | CA2310624A1 Chimeric pre-activated transcription factors |
| 05/27/1999 | CA2309763A1 Variable region fusion peptides that form effector complexes in the presence of antigen |
| 05/27/1999 | CA2309390A1 Cdk2 protein and cdk2 protein complexes |
| 05/27/1999 | CA2308571A1 Single-chain bifunctional glycoprotein hormones |
| 05/27/1999 | CA2308365A1 Dna19355 polypeptide, a tumor necrosis factor homolog |
| 05/27/1999 | CA2307539A1 Improvements relating to protein accumulation |
| 05/26/1999 | EP0917581A1 Fusion polypeptides com0prising an ige-binding domain and a hsa component, and their diagnostic and therapeutic uses |
| 05/26/1999 | CN1217750A Monoclonal antibody to CEA, Conjugates comprising said antibody, and their therapeutic use in ADEPT system |
| 05/25/1999 | US5906920 Methods for the detection of ligands for retinoid X receptors |
| 05/20/1999 | WO1999024594A1 Gene coding for thanatin, vector containing same and resulting transformed disease-resistant plants |
| 05/20/1999 | WO1999024570A1 Ciita-interacting proteins and methods of use therefor |
| 05/20/1999 | WO1999024470A1 Mammalian milk growth factor |
| 05/20/1999 | WO1999023867A2 Bmog, a protein member of the myelin-oligodendrocyte glycoprotein family and its use |
| 05/20/1999 | WO1999015653A3 Tie ligand homologues |
| 05/20/1999 | WO1999010506A9 Mosaic protein and restriction endonuclease assisted ligation method for making the same |
| 05/20/1999 | WO1999010494A3 Agonist antibodies to the thrombopoietin receptor, and their therapeutic uses |
| 05/20/1999 | WO1999006557A3 Mammalian cell membrane proteins; related reagents |
| 05/20/1999 | WO1999006549B1 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN TESTIS AND OTHER TISSUES |
| 05/20/1999 | WO1998051788A3 Method and construct for inhibition of cell migration |
| 05/20/1999 | CA2309323A1 Gene coding for thanatin, vector containing same and resulting transformed disease-resistant plants |
| 05/20/1999 | CA2309317A1 Bovine milk growth factor |
| 05/20/1999 | CA2308440A1 Bmog, a protein member of the myelin-oligodendrocyte glycoprotein family and its use |